MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Flexion Therapeutics Company Profile (NASDAQ:FLXN)

Consensus Ratings for Flexion Therapeutics (NASDAQ:FLXN) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $37.83 (152.81% upside)

Analysts' Ratings History for Flexion Therapeutics (NASDAQ:FLXN)
Show:
DateFirmActionRatingPrice TargetActions
6/28/2016BMO Capital MarketsInitiated CoverageOutperform$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016Janney Montgomery ScottReiterated RatingBuy$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2016Needham & Company LLCReiterated RatingBuy$28.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2016RBC CapitalReiterated RatingOutperform$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015Northland SecuritiesReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/30/2015MLV & Co.Initiated CoverageBuy$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2014Summer StreetReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Flexion Therapeutics (NASDAQ:FLXN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/12/2016Q1($0.61)($0.78)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3($0.60)($0.52)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.54)($0.58)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115($0.56)($0.43)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/31/2015($0.46)($0.47)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/13/2014Q314($0.55)($0.45)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014($0.52)($0.38)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2014($0.53)($0.86)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Flexion Therapeutics (NASDAQ:FLXN)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Flexion Therapeutics (NASDAQ:FLXN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Flexion Therapeutics (NASDAQ:FLXN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/21/2016Samuel D ColellaDirectorBuy25,504$13.71$349,659.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/20/2016Samuel D ColellaDirectorBuy6,778$13.84$93,807.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2016C Ann MerrifieldDirectorBuy1,000$13.39$13,390.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2016Samuel D ColellaDirectorBuy714,285$14.00$9,999,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Michael D ClaymanCEOBuy2,000$10.41$20,820.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Michael D ClaymanCEOBuy2,000$9.65$19,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Neil BodickInsiderBuy850$10.00$8,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Michael D ClaymanCEOBuy2,000$10.23$20,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Neil BodickInsiderBuy2,100$10.20$21,420.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Frederick W DriscollCFOBuy2,500$9.87$24,675.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Michael D ClaymanCEOBuy2,000$9.73$19,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2016Neil BodickInsiderBuy800$9.60$7,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Frederick W DriscollCFOBuy2,500$9.19$22,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Michael D ClaymanCEOBuy2,000$9.51$19,020.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016Neil BodickInsiderBuy1,250$9.22$11,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015C Ann MerrifieldDirectorBuy1,000$23.00$23,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015A/S NovoMajor ShareholderSell150,000$20.61$3,091,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Neil BodickInsiderSell4,000$25.28$101,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Neil BodickInsiderSell4,000$24.26$97,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/4/2015Neil BodickInsiderSell4,000$23.45$93,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Neil BodickInsiderSell4,000$22.44$89,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014A/S NovoMajor ShareholderBuy500,000$17.00$8,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014A/S NovoInsiderBuy692,308$13.00$9,000,004.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Bradley J Phd BolzonDirectorBuy307,692$13.00$3,999,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Sofinnova Partners SasMajor ShareholderBuy230,769$13.00$2,999,997.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Flexion Therapeutics (NASDAQ:FLXN)
DateHeadline
06/28/16 09:00 PMCheck on Share Volatility: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Engelwood Daily
06/22/16 08:43 AMFlexion Therapeutics Inc. (FLXN) Jumps 5.57% on June 20 - Equities.com
06/20/16 10:15 AMThis Weeks Broker Views For Flexion Therapeutics Inc (FLXN) - Fiscal Standard
06/16/16 03:31 PMFLEXION THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/16/16 08:24 AMFlexion Therapeutics Inc (FLXN) Current Analyst Ratings - Fiscal Standard
06/09/16 04:05 PMMedtronic PLC (NYSE:MDT) & Flexion Therapeutics (NASDAQ:FLXN) Healthcare Stock's Buzzers - Wall Street 24
06/09/16 04:05 PMAnalyst Recommended Stock: Flexion Therapeutics, Inc. (NASDAQ:FLXN) - News Oracle
06/09/16 04:05 PMAnalyst Overview on These 2 Stocks: Flexion Therapeutics, Inc. (NASDAQ:FLXN), Telefonica Brasil S.A. (NYSE:VIV) - Beacon Chronicle
06/08/16 04:14 PMFLEXION THERAPEUTICS INC. (NASDAQ:FLXN) Financial Condition Compared to S&P 500 - CML News
06/08/16 04:14 PMWhy Flexion Therapeutics Inc (FLXN), Micron Technology, Inc. (MU) and VeriFone Systems Inc (PAY) Are Three of ... - Investorplace.com
06/08/16 06:42 AMAfter-Hours Stock Movers 06/07: (GEVO) (HHS) (PLAY) Higher; (PAY) (FLXN) (DLTH) Lower (more...)
06/07/16 04:08 PMFlexion Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewswire (press release)
06/07/16 03:18 PMFlexion Therapeutics Announces Proposed Public Offering of Common Stock - [at noodls] - BURLINGTON, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering, subject to market and other conditions, ...
06/07/16 03:07 PMFLEXION THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/04/16 06:20 AM‘Sleepy’ Bedford biotech Anika wakes up investors with recent success -
06/03/16 06:20 AMFlexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for June 01 - Equities.com - Flexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for June 01Equities.comFlexion Therapeutics Inc. (FLXN) experienced unusually high volume on Jun. 01, as the stock lost 3.5% to a closing price of $16.83. The stock saw 576,781 shares trade hands over the course of the day on 3,440 trades. Given that the stock's average ...
06/02/16 04:15 PMFlexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Flexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Flexion Therapeutics Inc (FLXN). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
06/02/16 04:15 PMFlexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News - Flexion Therapeutics Inc (FLXN) Do Brokers Advise Buy, Sell Or Hold?Share Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Flexion Therapeutics Inc (FLXN). The latest reports which are currently in issue on Thursday 2nd of June state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...and more »
06/02/16 12:00 PMFlexion Therapeutics, Inc. :FLXN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 -
06/01/16 04:16 PMFlexion Therapeutics, Inc. (NASDAQ:FLXN) Soared 12.30%: Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC), Pitney ... - KC Register - Flexion Therapeutics, Inc. (NASDAQ:FLXN) Soared 12.30%: Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC), Pitney ...KC RegisterOn May 26, Flexion Therapeutics, Inc. (NASDAQ:FLXN) announces that it received written responses from the U.S. Food & Drug Administration (FDA) to questions the company had submitted in advance of a pre-NDA meeting regarding Flexion's lead product ...and more »
06/01/16 06:27 AMFlexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for May 30 - Equities.com - Flexion Therapeutics Inc. (FLXN) is Trading Lower on Unusual Volume for May 30Equities.comFlexion Therapeutics Inc. (FLXN) experienced unusually high volume on May. 30, as the stock lost 9.87% to a closing price of $15.53. The stock saw 1.05 million shares trade hands over the course of the day on 7,091 trades. Given that the stock's ...
06/01/16 06:27 AMFlexion Therapeutics Inc. (FLXN) Jumps 12.3% on May 31 - Equities.com - Flexion Therapeutics Inc. (FLXN) Jumps 12.3% on May 31Equities.comFlexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Tuesday May 31 as the stock popped 12.3% to $17.44, representing a gain of $1.91 per share. Some 815,146 shares traded hands on 5,241 trades, compared with an ...and more »
05/31/16 09:51 PMFlexion Therapeutics, Inc. (NASDAQ:FLXN) Stock Update & Estimates - Stock Tick Tock - Flexion Therapeutics, Inc. (NASDAQ:FLXN) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Flexion Therapeutics, Inc. (NASDAQ:FLXN) to post earnings of $-0.79 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be ...and more »
05/31/16 10:14 AMHealthcare Stocks to watch: Merck & Company, Inc. (NYSE:MRK) , Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Is stories - Is storiesHealthcare Stocks to watch: Merck & Company, Inc. (NYSE:MRK) , Flexion Therapeutics, Inc. (NASDAQ:FLXN)Is storiesIn most recently trading session on 5/27/2016, Flexion Therapeutics, Inc. (NASDAQ:FLXN) dropped -9.87% while traded on 1.05 million shares versus it's an average volume of 250.66 thousand shares. The company recorded the last trade with the price of ...and more »
05/31/16 10:14 AMAnalyst Overview on These Stocks: Flexion Therapeutics Inc (NASDAQ:FLXN), Shire PLC (ADR) (NASDAQ:SHPG) - Beacon Chronicle - Analyst Overview on These Stocks: Flexion Therapeutics Inc (NASDAQ:FLXN), Shire PLC (ADR) (NASDAQ:SHPG)Beacon ChronicleLast Trade: The Company closed its last session at $15.53 Friday with the loss of -9.87%. The market capitalization of the company is $301.94 million, with the average Volume of $264,719.00. The stock currently has its 52-Week High range of $29.09 and ...and more »
05/31/16 10:14 AMFlexion Therapeutics Inc (NASDAQ:FLXN) Dips After Upside Run; Discount Entry Opportunity? - Market Exclusive - Market ExclusiveFlexion Therapeutics Inc (NASDAQ:FLXN) Dips After Upside Run; Discount Entry Opportunity?Market ExclusiveFlexion Therapeutics Inc (NASDAQ:FLXN) just offered up some insight into its development pipeline prospects, and while the inference is positive, wider markets have taken a critical stance on the release. The company is down close to 10% on its Friday ...Flexion Therapeutics, Inc. (NASDAQ:FLXN) 1-Year High At $29.09Equities FocusFlexion Therapeutics, Inc. (NASDAQ:FLXN) Earns Consensus Buy RatingiStreetWireall 4 news articles »
05/29/16 12:40 PMFlexion Therapeutics, Inc. (NASDAQ:FLXN) Impact Score At 44 - Investor Newswire - Flexion Therapeutics, Inc. (NASDAQ:FLXN) Impact Score At 44Investor NewswireAlpha One explored various online articles released on Flexion Therapeutics, Inc. (NASDAQ:FLXN), and it set a daily sentiment score of 0.099 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring the ...and more »
05/29/16 12:40 PMFlexion Therapeutics Inc. (FLXN) Surged On FDA Feedback - RTT News - The Point ReviewFlexion Therapeutics Inc. (FLXN) Surged On FDA FeedbackRTT NewsFlexion Therapeutics Inc. (FLXN) announced Thursday morning that it has received positive feedback from the FDA regarding its new drug application for Zilretta. Based on the feedback, the in-person pre-NDA meeting has become unnecessary. Flexion ...Have a Glance at Flexion Therapeutics Inc (NASDAQ:FLXN)The Point ReviewFlexion Therapeutics Inc. (NASDAQ:FLXN) Receives Positive Guidance from FDA on New Drug ApplicationInside TradeAre Analysts Bullish Flexion Therapeutics Inc (NASDAQ:FLXN) After Last Week?The PostWall Street 24 -StreetInsider.comall 34 news articles »
05/28/16 12:03 PMHave a Glance at Flexion Therapeutics Inc (NASDAQ:FLXN) - The Point Review - The Point ReviewHave a Glance at Flexion Therapeutics Inc (NASDAQ:FLXN)The Point ReviewShare of Flexion Therapeutics Inc (NASDAQ:FLXN) traded on -11.03 percent below secure line at 2:28PM EDT in order to take the company's stock at the price of $15.33. At the time of writing the stock exchanged hands 822,944.00 shares versus average ...Flexion Therapeutics Inc. (FLXN) Surged On FDA FeedbackRTT NewsFlexion Therapeutics Inc. (NASDAQ:FLXN) Receives Positive Guidance from FDA on New Drug ApplicationInside TradeOvaScience Inc (NASDAQ:OVAS) & Flexion Therapeutics (NASDAQ:FLXN) Healthcare Stocks to WatchWall Street 24StreetInsider.com -The Postall 35 news articles »
05/27/16 01:06 PMAnalysts Actions to Track: Merck & Company, Inc. (NYSE:MRK) , Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Street Updates - Analysts Actions to Track: Merck & Company, Inc. (NYSE:MRK) , Flexion Therapeutics, Inc. (NASDAQ:FLXN)Street UpdatesOn 5/26/2016, shares of Merck & Company, Inc. (NYSE:MRK) fell -0.32% in trading session and finally closed at $56.39. The company most recent volume stood at 5.72 million shares as compared to average volume of 8.84 million shares. Over the one year ...and more »
05/27/16 01:06 PMHealthcare Traders Alert: Exelixis, Inc. (NASDAQ:EXEL), Flexion Therapeutics Inc (NASDAQ:FLXN) - NYSE Journal (press release) - Healthcare Traders Alert: Exelixis, Inc. (NASDAQ:EXEL), Flexion Therapeutics Inc (NASDAQ:FLXN)NYSE Journal (press release)On Thursday, Shares of Exelixis, Inc. (NASDAQ:EXEL), added 1.12% and closed at $6.30 in the last trading session. The last trading range of the stock ranges between $6.16 and $6.38. Exelixis, Inc. (EXEL) recently declared positive top-line results from ...and more »
05/27/16 01:06 PMScorching Healthcare Stock: Flexion Therapeutics Inc (NASDAQ:FLXN) - The Point Review - The Point ReviewScorching Healthcare Stock: Flexion Therapeutics Inc (NASDAQ:FLXN)The Point ReviewShare of Flexion Therapeutics Inc (NASDAQ:FLXN) traded on 35.02 percent above secure line at 2:23PM EDT in order to take the company's stock at the price of $15.49. At the time of writing the stock exchanged hands 1.50 million shares versus average ...Flexion Therapeutics Inc. (FLXN) Has Risen To Nearly A 4-Month High On FDA NewsRTT NewsOvaScience Inc (NASDAQ:OVAS) & Flexion Therapeutics (NASDAQ:FLXN) Healthcare Stocks to WatchWall Street 24Needham & Company Raises Price Target on Flexion Therapeutics (FLXN) to $34StreetInsider.comSeneca Globe -Street Wise Report (press release) (blog) -Sonoran Weekly Reviewall 29 news articles »
05/27/16 12:40 PM2 Sizzling-Hot Biotech Stocks to Buy -
05/27/16 07:12 AMFlexion (FLXN) Zilretta Gets Positive FDA Guidance; Stock Up -
05/26/16 12:08 PMInsiders Are Gradually Buying Flexion Therapeutics, Inc. (NASDAQ:FLXN) - Wall Street Hints and News - Insiders Are Gradually Buying Flexion Therapeutics, Inc. (NASDAQ:FLXN)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Flexion Therapeutics, Inc. (NASDAQ:FLXN) have increased their position in the stock by 30.18% over the past 6 months. Insiders now own 0.40% of total outstanding shares. There are both legal and illegal ...and more »
05/26/16 12:08 PMFlexion Therapeutics Inc. (FLXN) Has Risen To Nearly A 4-Month High On FDA News - RTT News - Boston Business Journal (blog)Flexion Therapeutics Inc. (FLXN) Has Risen To Nearly A 4-Month High On FDA NewsRTT NewsFlexion Therapeutics Inc. (FLXN) announced Thursday morning that it has received positive feedback from the FDA regarding its new drug application for Zilretta. Based on the feedback, the in-person pre-NDA meeting has become unnecessary. Flexion ...Flexion Therapeutics Gets Positive Feedback From FDA on New Application for Knee Treatment Drug Zilretta ...Sonoran Weekly ReviewFlexion shares hit 3-month high on FDA blessing to apply for drug approvalBoston Business Journal (blog)Thursday Morning's Market Insights: Abercrombie and Fitch Co. (ANF), OvaScience Inc (OVAS), Flexicon Therapeutics ...Smarter AnalystGlobeNewswire (press release) -Seeking Alphaall 6 news articles »
05/26/16 06:17 AMFlexion Therapeutics Receives Positive Guidance from FDA on New Drug Application (NDA) Submission for Zilretta™ for Osteoarthritis of the Knee - [at noodls] - BURLINGTON, Mass., May 26, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announces that yesterday it received written responses from the U.S. Food & Drug Administration (FDA) to questions ...
05/25/16 12:36 PMFlexion Therapeutics Inc. (FLXN) Jumps 8.87% on May 24 - Equities.com - Flexion Therapeutics Inc. (FLXN) Jumps 8.87% on May 24Equities.comFlexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Tuesday May 24 as the stock popped 8.87% to $11.54, representing a gain of $0.94 per share. Some 166,108 shares traded hands on 1,306 trades, compared with an ...and more »
05/21/16 12:24 PMThe CMO of Flexion Therapeutics (NASDAQ: FLXN) is Buying Shares - Analyst Ratings - The CMO of Flexion Therapeutics (NASDAQ: FLXN) is Buying SharesAnalyst RatingsOver the last month, Neil Bodick has reported 3 Buy trades on FLXN for a total of $40.63k. The company has a one year high of $29.09 and a one year low of $7.56. Currently, Flexion Therapeutics has an average volume of 128.6k. Starting in March 2014, ...Were Analysts Bullish Flexion Therapeutics Inc (NASDAQ:FLXN) This Week?The PostFlexion Therapeutics Inc (FLXN) Files Form 4 Insider Buying : Neil Bodick Buys 2100 SharesMarket DigestBroker Roundup For Flexion Therapeutics Inc (FLXN)Share Trading NewsTrade Calls -Wall Street Hints and News -Franklin Independentall 14 news articles »
05/21/16 12:24 PMFlexion Therapeutics Inc. (FLXN) Jumps 8.37% on May 20 - Equities.com - Flexion Therapeutics Inc. (FLXN) Jumps 8.37% on May 20Equities.comFlexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Friday May 20 as the stock popped 8.37% to $10.49, representing a gain of $0.81 per share. Some 128,376 shares traded hands on 1,247 trades, compared with an ...and more »
05/20/16 12:49 PMFlexion Therapeutics Inc. (FLXN) Jumps 6.67% on May 18 - Equities.com - Flexion Therapeutics Inc. (FLXN) Jumps 6.67% on May 18Equities.comFlexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Wednesday May 18 as the stock popped 6.67% to $10.24, representing a gain of $0.64 per share. Some 176,138 shares traded hands on 1,699 trades, compared with ...and more »
05/20/16 05:13 AMCynapsus Therapeutics Appoints Frederick Driscoll to Its Board of Directors - [at noodls] - TORONTO, May 20, 2016 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. ('Cynapsus' or the 'Company') (NASDAQ:CYNA) (TSX:CTH), a specialty central nervous system ('CNS') pharmaceutical company developing ...
05/19/16 12:04 PMFLEXION THERAPEUTICS INC Financials -
05/18/16 01:07 PMFlexion Therapeutics Inc. (FLXN) Jumps 10.51% on May 16 - Equities.com - Flexion Therapeutics Inc. (FLXN) Jumps 10.51% on May 16Equities.comFlexion Therapeutics Inc. (FLXN) was among the biggest gainers on the Russell 2000 for Monday May 16 as the stock popped 10.51% to $9.67, representing a gain of $0.92 per share. Some 247,037 shares traded hands on 2,179 trades, compared with an ...and more »
05/17/16 01:22 PMBroker Outlook For The Week Ahead Flexion Therapeutics Inc (FLXN) - Share Trading.News - Share Trading News - Broker Outlook For The Week Ahead Flexion Therapeutics Inc (FLXN) - Share Trading.NewsShare Trading NewsFlexion Therapeutics Inc (FLXN) has decreased by -52.57% over 12 months. Flexion Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with ...Flexion Therapeutics Incorporated (NASDAQ:FLXN) Sellers Increased By 0.39% Their ShortsFranklin IndependentFast Moving Stocks: Apple Inc. (NASDAQ:AAPL), ProNAi Therapeutics, Inc. (NASDAQ:DNAI), Flexion Therapeutics, Inc ...KC Registerall 4 news articles »
05/14/16 06:42 AMFlexion Therapeutics Inc. (FLXN) Drops 8.81% on May 12 - Equities.com - Flexion Therapeutics Inc. (FLXN) Drops 8.81% on May 12Equities.comFlexion Therapeutics Inc. (FLXN) was one of the Russell 2000's biggest losers for Thursday May 12 as the stock slid 8.81% to $8.59, a loss of $-0.83 per share. Starting at an opening price of $9.47 a share, the stock traded between $8.52 and $9.66 over ...and more »
05/13/16 11:42 AMEdited Transcript of FLXN earnings conference call or presentation 12-May-16 8:30pm GMT -
05/13/16 06:57 AMFlexion Therapeutics Inc. (FLXN) Drops 6.18% on May 11 - Equities.com - Flexion Therapeutics Inc. (FLXN) Drops 6.18% on May 11Equities.comFlexion Therapeutics Inc. (FLXN) was one of the Russell 2000's biggest losers for Wednesday May 11 as the stock slid 6.18% to $9.42, a loss of $-0.62 per share. Starting at an opening price of $10.08 a share, the stock traded between $9.38 and $10.12 ...and more »
05/12/16 04:27 PMFlexion Therapeutics Reports First-Quarter 2016 Financial Results - [at noodls] - Zilretta™, Flexion's non-opioid lead drug candidate (also known as FX006), completed pivotal Phase 2b and Phase 3 clinical registration trials, in patients with osteoarthritis (OA) of the knee Positive ...
05/12/16 03:19 PMFLEXION THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Notice of Delisting or Fa -
About Flexion Therapeutics

Flexion Therapeutics logoFlexion Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis and post-operative pain. The Company's portfolio of product candidates addresses the OA pain treatment spectrum, from moderate to severe pain. The Company's lead product candidate, Zilretta (also known as FX006), is a late-stage, injectable, sustained-release, intra-articular (IA) steroid for patients with moderate to severe OA pain. The Company's other product candidates include FX007, a preclinical, small-molecule tropomyosin receptor kinase A (TrkA) receptor antagonist designed to address post-operative pain, and FX005, a sustained-release p38 mitogen-activated protein (MAP), kinase inhibitor for the treatment of end-stage OA patients. The Company has not generated any revenue.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FLXN
  • CUSIP:
Key Metrics:
  • Previous Close: $14.97
  • 50 Day Moving Average: $13.512
  • 200 Day Moving Average: $13.023
  • P/E Ratio: N/A
  • P/E Growth: 0.000
  • Market Cap: $322.80M
  • Current Quarter EPS Consensus Estimate: $-2.920 EPS
Additional Links:
Flexion Therapeutics (NASDAQ:FLXN) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha